Skip to Main Content

Paper Details

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.
Clin Cancer Res
24
2022
Author NameAffiliation
Kelly L BoltonWashington University School of Medicine
Kelly L BoltonWashington University School of Medicine
Stacey J WinhamMayo Clinic
Sebastian M ArmasuMayo Clinic
Jenny LesterDavid Geffen School of Medicine, University of California at Los Angeles
Catherine J KennedyWestmead Hospital
Catherine J KennedyThe Westmead Institute for Medical Research
Anna M PiskorzUniversity of Cambridge
Alison BrandWestmead Hospital
Alison BrandThe University of Sydney
Yoke-Eng ChiewWestmead Hospital
Yoke-Eng ChiewThe Westmead Institute for Medical Research
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Ronny DrapkinUniversity of Pennsylvania
Ronny DrapkinUniversity of Pennsylvania
Anna DeFazioWestmead Hospital
Anna DeFazioThe University of Sydney
Anna DeFazioThe University of Sydney
Anna DeFazioThe Westmead Institute for Medical Research
Anna DeFazioWestmead Hospital
Anna DeFazioThe Westmead Institute for Medical Research
Anna DeFazioThe University of Sydney
Anna DeFazioThe University of Sydney
Beth Y KarlanDavid Geffen School of Medicine, University of California at Los Angeles
James D BrentonUniversity of Cambridge
Britta WeigeltMemorial Sloan-Kettering Cancer Center
Michael S AnglesioUniversity of British Columbia
Michael S AnglesioUniversity of British Columbia
David G HuntsmanUniversity of British Columbia
David G HuntsmanUniversity of British Columbia
Simon A GaytherCedars-Sinai Medical Center
Ellen L GoodeMayo Clinic
  • 1 - 33

Datasets

Release 1.2